the present invention relates to one or more of the phytocannabinoids tetrahydrocannabivarin ; cannabigerol ; cannabichromene ; and cannabidivarin for use in the treatment of intestinal inflammatory diseases . preferably the intestinal inflammatory disease is either ulcerative colitis or crohn &# 39 ; s disease .